Massachusetts General Hospital: Non-alcoholic Fatty Liver Disease trials

The registry lists 15 Non-alcoholic Fatty Liver Disease studies with Massachusetts General Hospital as lead sponsor. 2 are open to participants now and 11 have results posted.

Early Phase 1 1Phase 1 1Phase 2 4Phase 3 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver DiseaseNot yet recruitingNCT06166797
• Intermittent Fasting for NAFLD in AdultsRecruitingNCT04899102Not applicable
• Conditionally Increased Output (CIO) Enhanced Ultrasound SystemCompletedNCT05792423Not applicableResults posted
• The Impact of Ibutamoren on Nonalcoholic Fatty Liver DiseaseCompletedNCT05364684Phase 2Results posted
• Noninvasive Biomarkers of Metabolic Liver Disease 1.1CompletedNCT04828551Not applicableResults posted
• Aspirin for the Treatment of Nonalcoholic Fatty Liver DiseaseCompletedNCT04031729Phase 1/2Results posted
• Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular RiskCompletedNCT03375788Phase 2Results posted
• Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in AdolescentsCompletedNCT02726542Early Phase 1Results posted
• Effects of Pitavastatin on Insulin Sensitivity and Liver FatCompletedNCT02290106Not applicableResults posted
• Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT02217345Phase 2Results posted
• Tesamorelin Effects on Liver Fat and Histology in HIVCompletedNCT02196831Not applicableResults posted
• Ultrasound Method to Measure Fibrosis of the Liver in ChildrenTerminatedNCT02086708Not applicableResults posted
• Sonoelastography: Ultrasound Method to Measure Liver FibrosisCompletedNCT01747772Not applicableResults posted
• Estrogen Administration for the Treatment of NASH in Postmenopausal WomenActive, not recruitingNCT04833140Phase 3
• Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty LiverWithdrawnNCT01849081Not applicable